High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis

BACKGROUND: Urothelial carcinoma (UC) patients often bear clinical and genetic heterogeneity, which may differ in management and prognosis. Especially, patients with advanced/metastatic UC generally have a poor prognosis and survive for only few months. The Wnt/β-catenin signaling is found to be hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Hong-Yue, Chiu, Chia-Chun, Kuo, Yu-Hsuan, Tsai, Hsin-Hwa, Wu, Li-Ching, Tseng, Wen-Hsin, Liu, Chien-Liang, Hsing, Chung-Hsi, Huang, Steven K., Li, Chien-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965759/
https://www.ncbi.nlm.nih.gov/pubmed/35372028
http://dx.doi.org/10.3389/fonc.2022.834249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965759/
https://www.ncbi.nlm.nih.gov/pubmed/35372028
http://dx.doi.org/10.3389/fonc.2022.834249

Ejemplares similares